Fate Therapeutics, Inc. · NASDAQ:FATE

Redmile Group, LLC reported a 14.90% stake in Fate Therapeutics, Inc. (Schedule 13D/A)

Event Dec 20, 2024 · Filed Dec 26, 2024

Redmile Group, LLC reported a 14.90% stake in Fate Therapeutics, Inc., 17,816,634 shares, with active intent on Dec 20, 2024. Filed Dec 26, 2024 (Schedule 13D/A).

Stake
14.90%
Shares
17,816,634
Intent
Active
What changed
Stake changed
Filed together
3 holders

The filing in full

HolderStakeShares
Redmile Group, LLC14.90%17,816,634
Jeremy C. Green14.90%17,816,634
RedCo II Master Fund, L.P.8.50%9,787,689

Source

View original at SEC

Related